A post template

Bringing it home: SA is leading the charge to make anti-HIV jab for Africa 
/ 9 March 2026

Bringing it home: SA is leading the charge to make anti-HIV jab for Africa 

South Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July.

African Bank appoints new chief executive
/ 9 March 2026

African Bank appoints new chief executive

African Bank has appointed veteran banker Zweli Manyathi as its next chief executive as the lender enters what its board describes as a consolidation phase following several years of expansion and acquisitions. The bank announced that current group chief executive Kennedy Bungane will step down after five years in the role, during which he led […]